CA AB 1460
in committeePrescription drug pricing.
California · 2025-2026 Regular Session · lower
Quick answers
Did CA AB 1460 pass?
Not yet. CA AB 1460 is in committee as of 2025-07-16 and has not come to a final vote. Latest recorded action (2025-07-16): In committee: Hearing postponed by committee.
What is CA AB 1460 about?
Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law prohibits a pharmacy benefit manager from discriminating against a covered entity or its pharmacy in connection with dispensing a drug subject to federal pricing requirements or preventing a covered entity from retaining the benefit of discounted pricing for those drugs. This bill would prohibit a prescription drug manufacturer from engaging in discriminatory practices that would impose additional conditions, prohibit, restrict, deny, or interfere with a qualifying nonhospital 340B community clinic's purchase or delivery of a drug subject to federal pricing requirements if the qualifying nonhospital 340B community clinic utilizes a specified pharmacy, including a contract pharmacy, that dispenses the drug to an eligible patient of the qualifying nonhospital 340B community clinic. The bill would define "discriminatory practices" and "qualifying nonhospital 340B community clinic" for these purposes. The bill would require qualifying nonhospital 340B community clinics to annually perform specified activities to ensure compliance with program rules and guidance from the federal Health Resources and Services Administration. The bill would make related intent statements.
Who sponsors CA AB 1460?
Rogers is the primary sponsor of CA AB 1460, joined by 3 cosponsors.
Description
Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law prohibits a pharmacy benefit manager from discriminating against a covered entity or its pharmacy in connection with dispensing a drug subject to federal pricing requirements or preventing a covered entity from retaining the benefit of discounted pricing for those drugs. This bill would prohibit a prescription drug manufacturer from engaging in discriminatory practices that would impose additional conditions, prohibit, restrict, deny, or interfere with a qualifying nonhospital 340B community clinic's purchase or delivery of a drug subject to federal pricing requirements if the qualifying nonhospital 340B community clinic utilizes a specified pharmacy, including a contract pharmacy, that dispenses the drug to an eligible patient of the qualifying nonhospital 340B community clinic. The bill would define "discriminatory practices" and "qualifying nonhospital 340B community clinic" for these purposes. The bill would require qualifying nonhospital 340B community clinics to annually perform specified activities to ensure compliance with program rules and guidance from the federal Health Resources and Services Administration. The bill would make related intent statements.
- Introduced
- 2025-02-21
- Latest action
- 2025-07-16 — In committee: Hearing postponed by committee.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Rogersauthor
- Carrillocoauthor
- Ransomcoauthor
- Wardcoauthor
Committees
Not provided by source.
Action timeline
2025-02-21
Introduced. To print.
introduction
2025-02-22
From printer. May be heard in committee March 24.
2025-02-24
Read first time.
reading-1
2025-03-24
Referred to Com. on HEALTH.
referral-committee
2025-04-23
From committee: Amend, and do pass as amended. (Ayes 9. Noes 4.) (April 22).
amendment-introduction,amendment-passage,committee-passage
2025-04-24
Read second time and amended. Ordered returned to second reading.
amendment-passage,reading-1,reading-2
2025-04-28
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2025-05-19
Read third time. Passed. Ordered to the Senate. (Ayes 44. Noes 6. Page 1589.)
passage,reading-1,reading-3
2025-05-20
In Senate. Read first time. To Com. on RLS. for assignment.
reading-1,referral-committee
2025-05-28
Referred to Com. on HEALTH.
referral-committee
2025-06-25
In committee: Set, first hearing. Hearing canceled at the request of author.
2025-06-27
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2025-07-02
In committee: Set, second hearing. Hearing canceled at the request of author.
2025-07-16
In committee: Hearing postponed by committee.
Versions
Documents
- application/pdf
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
Do pass as amended.
2025-04-22 · pass · 9-4
Member-level votes (16)
- Celeste Rodriguez: yes
- Bonta: yes
- Mark González: yes
- Aguiar-Curry: yes
- Schiavo: yes
- Addis: yes
- Sanchez: no
- Flora: no
- Patterson: no
- Krell: no
- Chen: other
- Patel: other
- Stefani: other
- Rogers: yes
- Sharp-Collins: yes
- Carrillo: yes
AB 1460 Rogers Assembly Third Reading
2025-05-19 · pass · 44-6
Member-level votes (79)
- Zbur: yes
- Fong: yes
- Kalra: yes
- Ransom: yes
- Rivas: yes
- Ramos: yes
- Pellerin: yes
- Muratsuchi: yes
- Wilson: yes
- Ortega: yes
- Schultz: yes
- Boerner: yes
- Wicks: yes
- Sharp-Collins: yes
- Haney: yes
- Gabriel: yes
- Harabedian: yes
- Bennett: yes
- Bonta: yes
- Addis: yes
- Ward: yes
- Mark González: yes
- Quirk-Silva: yes
- Lowenthal: yes
- Celeste Rodriguez: yes
- Ahrens: yes
- Jackson: yes
- Bauer-Kahan: yes
- Berman: yes
- Bains: yes
- Garcia: yes
- Aguiar-Curry: yes
- Alvarez: yes
- Connolly: yes
- Gipson: yes
- Bryan: yes
- Schiavo: yes
- Rogers: yes
- Caloza: yes
- McKinnor: yes
- Elhawary: yes
- Carrillo: yes
- Lee: yes
- Ávila Farías: yes
- Chen: no
- DeMaio: no
- Patterson: no
- Gallagher: no
- Davies: no
- Sanchez: no
- Solache: other
- Michelle Rodriguez: other
- Soria: other
- Nguyen: other
- Pacheco: other
- Dixon: other
- Wallis: other
- Krell: other
- Arambula: other
- Jeff Gonzalez: other
- Hart: other
- Valencia: other
- Ta: other
- Macedo: other
- Stefani: other
- Hoover: other
- Tangipa: other
- Blanca Rubio: other
- Ellis: other
- Papan: other
- Castillo: other
- Hadwick: other
- Patel: other
- Alanis: other
- Calderon: other
- Flora: other
- Irwin: other
- Lackey: other
- Petrie-Norris: other
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 1460. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.